Search details
1.
Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Nature
; 554(7693): 554, 2018 02 22.
Article
in English
| MEDLINE | ID: mdl-29342137
2.
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 383(24): 2345-2357, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-32955174
3.
Olaparib for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 382(22): 2091-2102, 2020 05 28.
Article
in English
| MEDLINE | ID: mdl-32343890
4.
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Nature
; 547(7661): 109-113, 2017 07 06.
Article
in English
| MEDLINE | ID: mdl-28658205
5.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 23(3): 362-373, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35131040
6.
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial.
Lancet
; 398(10295): 131-142, 2021 07 10.
Article
in English
| MEDLINE | ID: mdl-34246347
7.
Implications of DNA damage repair alterations for the management of prostate cancer.
Curr Opin Urol
; 32(3): 302-310, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35266912
8.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate
; 81(16): 1382-1389, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34516663
9.
Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer.
Br J Cancer
; 124(3): 552-563, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33106584
10.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
N Engl J Med
; 378(15): 1408-1418, 2018 Apr 12.
Article
in English
| MEDLINE | ID: mdl-29420164
11.
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study).
Br J Cancer
; 119(9): 1052-1059, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30131546
12.
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)".
Int J Cancer
; 151(12): 2291-2292, 2022 Dec 15.
Article
in English
| MEDLINE | ID: mdl-35975447
13.
Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
Pediatr Blood Cancer
; 64(7)2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28035744
14.
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies.
Br J Cancer
; 114(8): 889-96, 2016 Apr 12.
Article
in English
| MEDLINE | ID: mdl-27002938
15.
A robust blood gene expression-based prognostic model for castration-resistant prostate cancer.
BMC Med
; 13: 201, 2015 Aug 21.
Article
in English
| MEDLINE | ID: mdl-26297150
16.
Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
Gynecol Oncol
; 133(3): 632-9, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24657303
17.
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
Future Oncol
; 10(2): 219-31, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24490608
18.
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.
J Clin Oncol
; 42(5): 571-583, 2024 Feb 10.
Article
in English
| MEDLINE | ID: mdl-37963304
19.
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.
Eur Urol Open Sci
; 61: 44-51, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38384439
20.
Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
BJU Int
; 112(5): 666-73, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23320731